Det er aktuelt ikke afklaret, om langtidsbehandling af patienter med SCN gør disse patienter disponeret for cytogenetiske anomalier, myelodysplastiske syndromer eller leukæmisk transformation.
It is currently unclear whether long-term treatment of patients with SCN will predispose patients to cytogenetic abnormalities, MDS or leukaemic transformation.